BEIJING AOSAIKANG revenue for the last year amounted to 1.44 B CNY, the most of which — 616.95 M CNY — came from its highest performing source at the moment, Anti-Tumor, the year earlier bringing 651.41 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought BEIJING AOSAIKANG 1.44 B CNY, and the year before that — 1.87 B CNY.